These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 506600)

  • 41. Expansion and retention of pulmonary CD4
    Roberts LM; Wehrly TD; Crane DD; Bosio CM
    Vaccine; 2017 May; 35(19):2575-2581. PubMed ID: 28372827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mosquitoes (Diptera: Culicidae), in contrast to ticks (Acari: Ixodidae), do not carry Francisella tularensis in a natural focus of tularemia in the Czech Republic.
    Hubálek Z; Halouzka J
    J Med Entomol; 1997 Nov; 34(6):660-3. PubMed ID: 9439120
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Basic types of functioning of parasitic systems in natural foci infections].
    Kulik IL
    Med Parazitol (Mosk); 1979; 48(3):3-9. PubMed ID: 379566
    [No Abstract]   [Full Text] [Related]  

  • 44. [The effect of aerosolization on the changes in major biological properties of the vaccine strain of Francisella tularensis].
    Koniukhov VF; Petrosov VV; Meshcheriakova IS; Savel'eva RA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Jun; (6):26-9. PubMed ID: 6613417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Investigation of the presence of Francisella tularensis by culture, serology and molecular methods in mice of Thrace Region, Turkey].
    Unal Yilmaz G; Gurcan S; Ozkan B; Karadenizli A
    Mikrobiyol Bul; 2014 Apr; 48(2):213-22. PubMed ID: 24819259
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Current state of tularemia foci of meadow-field type in the European USSR].
    Olsuf'ev NG; Dobrokhotov BP; Dunaeva TN; Petrov VG
    Zh Mikrobiol Epidemiol Immunobiol; 1971; 48(6):117-21. PubMed ID: 4255103
    [No Abstract]   [Full Text] [Related]  

  • 47. Tularemia: the disease and the weapon.
    Cronquist SD
    Dermatol Clin; 2004 Jul; 22(3):313-20, vi-vii. PubMed ID: 15207312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Ecological approaches to the study of natural-focus diseases].
    Tarasov VV
    Med Parazitol (Mosk); 1990; (3):3-5. PubMed ID: 2215369
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tularemia.
    Feldman RA; Koehler RE
    JAMA; 1973 Oct; 226(2):189. PubMed ID: 4740911
    [No Abstract]   [Full Text] [Related]  

  • 50. Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.
    Wayne Conlan J; Shen H; Kuolee R; Zhao X; Chen W
    Vaccine; 2005 Mar; 23(19):2477-85. PubMed ID: 15752834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tularemia vaccines.
    Putzova D; Senitkova I; Stulik J
    Folia Microbiol (Praha); 2016 Nov; 61(6):495-504. PubMed ID: 27194547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The epizootic characteristics of tularemia in the Crimea].
    Alekseev AF; Chirniĭ VI; Bogatyreva LM; Tovpinets NN; Evstaf'ev IL; Markeshin SIa; Kovin VV; Evstratov IuV; Zakharova TF; Galushko VI
    Zh Mikrobiol Epidemiol Immunobiol; 1996; (6):28-32. PubMed ID: 9103072
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tularemia vaccines: recent developments and remaining hurdles.
    Conlan JW
    Future Microbiol; 2011 Apr; 6(4):391-405. PubMed ID: 21526941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dominance of human innate immune responses in primary Francisella tularensis live vaccine strain vaccination.
    Fuller CL; Brittingham KC; Hepburn MJ; Martin JW; Petitt PL; Pittman PR; Bavari S
    J Allergy Clin Immunol; 2006 May; 117(5):1186-8. PubMed ID: 16675351
    [No Abstract]   [Full Text] [Related]  

  • 56. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
    Jia Q; Horwitz MA
    Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
    [No Abstract]   [Full Text] [Related]  

  • 57. From rabbits to humans: the contributions of Dr. Theodore E. Woodward to tularemia research.
    Cross AS; Calia FM; Edelman R
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S61-7. PubMed ID: 17582573
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Tularemia in the Orenburg region. II].
    Volkova LA; Iushkin GV
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Feb; 46(2):119-20. PubMed ID: 4239988
    [No Abstract]   [Full Text] [Related]  

  • 59. Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial.
    Mulligan MJ; Stapleton JT; Keitel WA; Frey SE; Chen WH; Rouphael N; Edupuganti S; Beck A; Winokur PL; El Sahly HM; Patel SM; Atmar RL; Graham I; Anderson E; El-Kamary SS; Pasetti MF; Sztein MB; Hill H; Goll JB;
    Vaccine; 2017 Aug; 35(36):4730-4737. PubMed ID: 28750854
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Tularemia ("rabbit plague")].
    Hassler D; Schwarz TF; Braun R
    Dtsch Med Wochenschr; 2003 Jan; 128(3):70. PubMed ID: 12596770
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.